Title : Safety and efficacy of transdermal buprenorphine for the relief of cancer pain.

Pub. Date : 2013 Dec

PMID : 23922192






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Two studies (n = 288) assessed "responders" and showed a significant difference between TD buprenorphine and placebo in all three doses of TD buprenorphine, 35.5, 52.5, or 70 mug/h (RR 1.74, 95 % CI 1.31-2.32; I (2) 0 %); the numbers-needed-to-treat was 5.8 (3.9-11). Buprenorphine ribonucleotide reductase catalytic subunit M1 Homo sapiens